about Madhu Kumar
As an undergraduate at the University of Pennsylvania, Madhu Kumar conducted analysis on the mutation of BRAF, NRAS, and KRAS genes in several types of cancer, graduating summa cum laude with a BA in biochemistry and chemistry. He undertook doctoral studies in biology at the Massachusetts Institute of Technology (MIT), where he received the National Science Foundation Graduate Research Fellowship and the MIT Ludwig Graduate Research Fellowship. While pursuing his research at MIT, Madhu Kumar published several papers on the relation between microRNA and cancer occurrence, including an article in the Proceedings of the National Academy of Sciences on the suppression of lung tumor development.
After earning his PhD, Madhu Kumar received the Human Frontier Science Program Long-Term Fellowship and the European Molecular Biology Organization Long-Term Fellowship. He completed postdoctoral fellowship training at the Cancer Research UK London Research Institute, performing investigations in such areas as the function of GATA2 in the survival of RAS-driven lung tumors. Subsequently, Mr. Kumar joined University Health Network and worked on immune checkpoint therapy and the use of circulating tumor DNA as a lung cancer diagnostic. He most recently served as a scientific advisor for Wilson Sonsini Goodrich and Rosati, handling national and international patent applications for technologies in various industries.
Also active in the White Plains, New York, community, Mr. Kumar volunteers as a mentor for the White Plains Youth Bureau. He also gives his time as a tutor for the nonprofits Girls Inc. and Latino U.